Multi-Cancer Early Detection (MCED) blood test
Just One Blood Draw. One Simple Step.
“Cancer” and “peace of mind” can go together by embracing groundbreaking innovations like Multi-Cancer Early Detection (MCED) testing, which makes a game-changing advancement in preventive care possible.
Today, we have the tools to treat cancer far more effectively, especially when it’s detected early. But we can’t treat what we haven’t found.
While traditional screenings like mammograms and colonoscopies are helpful, they only target about five specific cancer types. Yet, over 70% of cancer deaths are caused by cancers for which no standard screening exists. That’s where MCED testing comes in.
The MCED can screen for up to 50 or more types of cancer through a single blood draw and is embraced as a powerful tool in the shift toward proactive, preventive, and personalized care.
These tests, often based on liquid biopsy technology, analyze fragments of DNA (known as circulating tumor DNA, or ctDNA) that are shed into the bloodstream by cancer cells.
By identifying abnormal methylation patterns or genetic mutations, these tests can detect cancer before symptoms arise, potentially at very early, more treatable stages.
We view this advancement not as a standalone diagnostic, but as a means to enhance early detection strategies for individuals at high risk or those with unexplained symptoms, a strong family history, or environmental exposures.
When used thoughtfully, the test can complement traditional screenings and offer a broader view of systemic cancer risk, especially for rare or difficult-to-detect cancers.
If cancer markers are identified, our practitioners will not only refer patients for appropriate conventional diagnostics and oncology care but will also conduct a thorough investigation into the underlying factors that may contribute to cancer vulnerability. This investigation will include examining toxin exposure and the body's detoxification capacity, assessing chronic inflammation and immune function, evaluating nutritional status and mitochondrial health, considering epigenetic and lifestyle factors, analyzing gut health and microbiome imbalances, and addressing oxidative stress and hormone dysregulation.
The custom-tailored response plan may include: anti-inflammatory, plant-rich dietary changes; targeted supplementation with antioxidants, immune modulators, or detox support; stress-reduction practices and circadian rhythm optimization; support for liver and lymphatic detox pathways; and a referral to integrative oncology or collaborative specialists as needed.
We embrace tools like the MCED blood test as part of a precision health strategy—utilizing advanced technology not only to detect disease but also to guide a personalized prevention and healing plan that supports the body at every level.
The goal is not fear, but empowerment—helping patients catch disease early, take proactive steps, and optimize their long-term health trajectory.
